Shareholding for the Period Ended March 31, 2018
Clariant Chemicals (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here11-04-2018
Shareholding for the Period Ended March 31, 2018
Clariant Chemicals (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click hereBoard Meeting Intimation for Results & Closure of Trading Window
Clariant Chemicals (India) Ltd has informed BSE that a Meeting of Board of Directors of the Company will be held on May 15, 2018, inter alia, to consider and take on record the Audited Financial Results for the year ended March 31, 2018.In compliance with Code of Conduct framed by the Company for Prohibition of Insider Trading pursuant to the requirement of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window...Un-Audited Financial Results Along With The Limited Review Report For The 3Rd Quarter Ended December 31, 2017
Dear Sir/Madam, We wish to inform you that the Board of Directors of the Company, at their meeting held on February 13, 2018, inter alia, approved and taken on record the Un-Audited Financial Results along with the Limited Review Report for the 3rd quarter ended December 31, 2017. Pursuant to Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulation 2015, enclosing herewith Un-Audited Financial Results along...Announcement under Regulation 30 (LODR)-Press Release / Media Release
Dear Sir, We are attaching herewith Media Release titled 'Clariant Q3 2017-18 sales grow by 13.4%' for your information and record. Kindly take the above document on record.Board Meeting-Outcome of Board Meeting
Dear Sir/Madam, We wish to inform you that the Board of Directors of the Company, at their meeting held on February 13, 2018, inter alia, approved and taken on record the Un-Audited Financial Results along with the Limited Review Report for the 3rd quarter ended December 31, 2017. Pursuant to Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulation 2015, enclosing herewith Un-Audited Financial Results along...Clariant in India opens healthcare packaging plant
Chemical manufacturing company Clariant in India inaugurated its new healthcare packaging plant in Cuddalore today.Ketan Premani, India Head of Business Unit - Medical Specialties, said in a press...Shareholding for the Period Ended December 31, 2017
Clariant Chemicals (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click hereNotice Of Board Meeting And Intimation Of Closure Of Trading Window
Dear Sir/Madam, Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we wish to inform you that a Meeting of Board of Directors of the Company will be held on Tuesday, February 13, 2018, inter alia, to consider and take on record the Un-Audited Financial Results for the 3rd quarter ended December 31, 2017....Clariant to showcase nextgen drug packaging delivery devices, Mevopur & RemafinEP at MD&M; 2018
Clariant, a world leader in specialty chemicals, will share how its Mevopur and RemafinEP products can help in 'futureproofing' pharmaceutical packaging and drugdelivery devices in advance of new USP<661.1> regulations at the upcoming MD&M West exhibition.Newspaper Publication
Newspaper Advertisement for transfer of equity shares of the Company to the Investor Education and Protection Fund. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copies of the advertisement published in the newspaper dated November 20, 2017, titled -Transfer of Equity Shares of the Company to Investor Education and Protection Fund (IEPF) Account....